Inventor · disambiguated record
Kuo-Shyan Lin
Also filed as: LIN KUO-SHYAN
10 granted patents·16 pending applications·18 citations·filing 2013–2025
83Inventor score
Files withPROVINCIAL HEALTH SERVICES AUTHORITY18BRITISH COLUMBIA CANCER AGENCY BRANCH3ADMARE THERAPEUTICS SOC2UNIV BRITISH COLUMBIA2THE GOVERNERS OF THE UNIV OF ALBERTA THE UNIV OF BRITISH COLUMBIA CARLETON UNIV SIMON FRASER UNIV TH1
Top patents by PatentIndex Score
26 records- 0193US11395857B2Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Granted Jul 26, 2022·3 cites·33 claims
- 0286US10150804B2Compositions and methods for imaging cancerBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2015·Granted Dec 11, 2018·6 cites·19 claims
- 0385US11504441B2Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Granted Nov 22, 2022·1 cites·20 claims
- 0480US10882871B218/19F-labelled compounds which target the prostate specific membrane antigenBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2017·Granted Jan 5, 2021·3 cites·20 claims
- 0578US2024350681A1Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2024·Application pending·0 cites
- 0676US12246076B2Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Granted Mar 11, 2025·0 cites·14 claims
- 0774US2024342321A1Novel cxcr4-targeting compoundsPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2024·Application pending·0 cites
- 0872US12427209B2Dual mode 18F-labelled theranostic compounds and uses thereofPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Granted Sep 30, 2025·1 cites·5 claims
- 0969US2023348535A1Radiometal-binding compounds for diagnosis or treatment of prostate specific membrane antigen-expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 1068US11992537B2Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Granted May 28, 2024·0 cites·20 claims
- 1163US9865367B2Process and apparatus for separation of technetium-99M from molybdateTHE GOVERNERS OF THE UNIV OF ALBERTA THE UNIV OF BRITISH COLUMBIA CARLETON UNIV SIMON FRASER UNIV TH·Filed 2013·Granted Jan 9, 2018·3 cites·18 claims
- 1262US2024100203A1Novel cxcr4-targeting compoundsPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Application pending·0 cites
- 1361US2025161501A1Radiolabeled Compounds for Imaging of Fibroblast Activation Protein (FAP) and Treatment of FAP-Related DisordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 1460US10039846B2Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disordersBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2013·Granted Aug 7, 2018·1 cites·11 claims
- 1559US2023114807A1Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2022·Application pending·0 cites
- 1659US2025242064A1Cxcr4-targeting compounds, and methods of making and using the samePROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 1757US2025195702A1Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2025·Application pending·0 cites
- 1852US2025186627A1Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 1951US2020339625A1Novel radiometal-binding compounds for diagnosis or treatment of prostate specific membrane antigen-expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2018·Application pending·0 cites
- 2049US2022218852A1Novel radiolabelled cxcr4-targeting compounds for diagnosis and therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2020·Application pending·0 cites
- 2147US12472272B2Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen- expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2020·Granted Nov 18, 2025·0 cites·40 claims
- 2247US2024309070A1Anti-vaccinia virus antigen antibodies and related compositions and methodsADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 2346US2023027475A1Anti-oncolytic virus antigen antibodies and methods of using sameADMARE THERAPEUTICS SOC·Filed 2020·Application pending·0 cites
- 2445US2024018110A1Radiolabeled compounds targeting the prostate-specific membrane antigenUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 2543US2021402016A1Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Application pending·0 cites
- 2641US2022160908A1Chelators and methods of making and using sameUNIV BRITISH COLUMBIA·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →